Published on | 3 years ago
Programmes EIC New European Bauhaus Green DealIn the European Innovation Council 2022 work programme four recognition prizes are included with upcoming calls for applications.
More info on how to apply for the competitions
“The European Innovation Procurement Awards aim to recognise public and private buyers, natural persons and those legal entities supporting these practices across Europe in their efforts to promote and stimulate innovation procurement and the innovative ways the solutions are procured. The Awards also aims to demonstrate how innovation procurement positively transforms the economy by not only creating new and sustainable markets, but also by tackling societal challenges such as climate change.” (EIC 2022 WP). There are three categories. In each category a winner will be awarded with 75.000 euro (1st ranked) and one runner up (ranked 2nd) with 25.000 euro.
The prize awards cities that boost the local innovation ecosystem and new activities aimed at game-changing innovation. There are two categories:
The prize celebrates women who have founded an innovative company. There are two categories:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.